ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Genor Biopharma Holdings Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate 18.34% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -241.82
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -21.27%, its profits have risen by 103.7% ; the PEG ratio of the company is 2.6
3
Below par performance in long term as well as near term
- Along with generating -21.27% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Genor Biopharma Holdings Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Genor Biopharma Holdings Ltd.
-21.27%
0.85
80.85%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
176.53%
EBIT Growth (5y)
18.34%
EBIT to Interest (avg)
-241.82
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.92
Sales to Capital Employed (avg)
0.11
Tax Ratio
50.99%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
266
Industry P/E
Price to Book Value
4.66
EV to EBIT
-122.66
EV to EBITDA
-187.62
EV to Capital Employed
46.16
EV to Sales
18.57
PEG Ratio
2.56
Dividend Yield
NA
ROCE (Latest)
-37.63%
ROE (Latest)
1.76%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
NET SALES(HY)
Higher at HKD 2,687.88 MM
ROCE(HY)
Highest at 15.88%
RAW MATERIAL COST(Y)
Fallen by -6,773% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 8.09 times
OPERATING PROFIT(Q)
Highest at HKD 850.68 MM
PRE-TAX PROFIT(Q)
Highest at HKD 598.04 MM
NET PROFIT(Q)
Highest at HKD 496.51 MM
EPS(Q)
Highest at HKD 0.37
-1What is not working for the Company
INTEREST(Q)
Highest at HKD 148.45 MM
Here's what is working for Genor Biopharma Holdings Ltd.
Pre-Tax Profit
At HKD 598.04 MM has Grown at 496.41%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD 496.51 MM has Grown at 515.07%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (HKD MM)
Net Sales
Higher at HKD 2,687.88 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (HKD MM)
Operating Profit
Highest at HKD 850.68 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (HKD MM)
Pre-Tax Profit
Highest at HKD 598.04 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
Highest at HKD 496.51 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
EPS
Highest at HKD 0.37
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Debtors Turnover Ratio
Highest at 8.09 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -6,773% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Genor Biopharma Holdings Ltd.
Interest
Highest at HKD 148.45 MM
in the last five periods and Increased by 4,616.9% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
